Ben Haynor analyst LAKE STREET

Currently out of the existing stock ratings of Ben Haynor, 130 are a BUY (89.04%), 16 are a HOLD (10.96%).

Ben Haynor

Work Performance Price Targets & Ratings Chart

Analyst Ben Haynor, currently employed at LAKE STREET, carries an average stock price target met ratio of 39.82% that have a potential upside of 42.84% achieved within 229 days.

Ben Haynor’s has documented 274 price targets and ratings displayed on 36 stocks. The coverage is on Healthcare, Technology, Basic Materials, Industrials sectors.

Most recent stock forecast was given on ELMD, Electromed at 26-Aug-2026.

Wall Street Analyst Ben Haynor

Analyst best performing recommendations are on PIII (P3 HEALTH PARTNERS).
The best stock recommendation documented was for DRIO (DARIOHEALTH CORP) at 8/17/2021. The price target of $255 was fulfilled within 10 days with a profit of $43.8 (20.74%) receiving and performance score of 20.74.

Average potential price target upside

DRIO DarioHealth Corp EYEG AB Corporate Bond ETF HSKA Heska ICCM Icecure Medical IMAC Imac Holdings KIN Kindred Biosciences MYO Myomo OPGN OpGen PROF Profound Medical Corp RSLS ReShape Lifesciences TTOO T2 Biosystms PODD Insulet KPRX Kiora Pharmaceuticals MOTS Motus GI Holdings VIVE Viveve Medical SRTS Sensus Healthcare ITMR Itamar Medical Ltd NSPR InspireMD BEAT Heartbeam BIOC Biocept EKSO Ekso Bionics Holdings BFLY Butterfly Network TCMD Tactile Systems Technology TMCI Treace Medical Concepts KIDS Orthopediatrics Corp PIII P3 Health Partners ATEC Alphatec Holdings IT Gartner RS Reliance Steel & Aluminum Co TT Trane Technologies plc VIV Telefonica Brasil SA ADR VSAT ViaSat NMTC Neuroone Medical Technologies Corp ELMD Electromed FEMY Femasys NUTX Nutex Health

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 13-Aug-2025

$8

$2.2 (37.93%)

$11

2 months ago
(12-Aug-2026)

2/9 (22.22%)

$0.52 (6.95%)

41

Buy Since 22-Mar-2021

$10

$4.2 (72.41%)

$16

6 months 22 days ago
(20-Mar-2026)

0/11 (0%)

$2.01 (25.16%)

Buy Since 16-Nov-2022

3 years 2 months 1 days ago
(11-Aug-2023)

4/7 (57.14%)

$57.8 (49.32%)

215

Buy Since 22-Jun-2020

$160

$154.2 (2658.62%)

$200

3 years 2 months 5 days ago
(07-Aug-2023)

1/2 (50%)

$92.6 (137.39%)

39

Buy Since 06-Jun-2019

$540

3 years 5 months ago
(12-May-2023)

4/5 (80%)

$146.4 (37.20%)

176

Show more analysts

Please expand the browser size to see the chart

Which stock is Ben Haynor most bullish on?

Potential upside of $103.71 has been obtained for NUTX (NUTEX HEALTH)

Which stock is Ben Haynor most reserved on?

Potential downside of $1.05 has been obtained for SRTS (SENSUS HEALTHCARE)

What Year was the first public recommendation made by Ben Haynor?

On 2012
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?